Kyparissia Sirinakis - Profile and Investment Details

Investor Profile

Kyparissia Sirinakis is a Venture Capital, Private Equity Firm, Micro VC, Investment Partner based in Bethesda, Maryland, United States with a diverse investment portfolio that includes companies such as Confluence Life Sciences, FTEN, Funderbeam, Edinburgh Molecular Imaging, USM Maryland Momentum Fund, Topas Therapeutics, MASA Life Science Ventures, Caldan Therapeutics, Theolytics, Macomics, Eternygen, Virginia Catalyst, NodThera, Clyde Biosciences, Virginia Bio, Enterprise Therapeutics, AdoRx Therapeutics, Tech Council of Maryland, Southeast BIO, Apellis Pharmaceuticals, Mironid, Sirakoss, George Mason University, Technology Resource Alliance, IGEM Therapeutics, Libra Therapeutics, Lunac Therapeutics, WomenAngels.net LLC, . Over time, Kyparissia Sirinakis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kyparissia Sirinakis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, High-growth Startups, Wellness, Fundraising, Equities, Healthcare Innovation, Chemical, Life Science, Health Technology, Venture Fundraising, Finance, Intellectual Property, Biotechnology, Medical Devices, Genomics, Medical, B2B, Therapeutics, Advanced Materials, Health Tech, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Kyparissia Sirinakis, as their portfolio suggests a familiarity and interest in this area.

Understanding Kyparissia Sirinakis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.